{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:50:36Z","timestamp":1788825036472,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejoncologynursing.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Oncology Nursing"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejon.2025.103014","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T09:56:35Z","timestamp":1760694995000},"page":"103014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["German cancer nurses and occupational exposure to cytotoxic drugs: A cross-sectional study with a mixed-methods approach"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3169-1812","authenticated-orcid":false,"given":"Matthias","family":"Naegele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejon.2025.103014_bib1","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1111\/jocn.17488","article-title":"Global cancer nurse's experiences and perceptions of potential occupational exposure to cytotoxic drugs: mixed method systematic review with framework synthesis","volume":"33","author":"Campbell","year":"2024","journal-title":"J. Clin. Nurs."},{"issue":"6","key":"10.1016\/j.ejon.2025.103014_bib2","first-page":"354","article-title":"Preventing occupational exposures to antineoplastic drugs in health care settings","volume":"56","author":"Connor","year":"2006","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.ejon.2025.103014_bib3","first-page":"314","article-title":"The evolution of oncology nursing: leading the path to change","volume":"28","author":"Cummings","year":"2018","journal-title":"Can. Oncol. Nurs. J."},{"issue":"10","key":"10.1016\/j.ejon.2025.103014_bib31","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.12968\/bjon.2022.31.10.S26","article-title":"Closed safety system for administration (CSSA): proposal for a new cytotoxic chemotherapy acronym","volume":"31","author":"Eisenberg","year":"2022","journal-title":"Br. J. Nurs"},{"key":"10.1016\/j.ejon.2025.103014_bib5","series-title":"Guidance for the Safe Management of Hazardous Medicinal Products at Work","year":"2023"},{"key":"10.1016\/j.ejon.2025.103014_bib6","series-title":"Study Supporting the Assessment of Different Options Concerning the Protection of Workers from Exposure to Hazardous Medicinal Products, Including Cytotoxic Medicinal Products \u2013 Final Report","year":"2021"},{"issue":"5","key":"10.1016\/j.ejon.2025.103014_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00420-004-0595-1","article-title":"Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities","volume":"78","author":"Fransman","year":"2005","journal-title":"Int. Arch. Occup. Environ. Health"},{"issue":"1","key":"10.1016\/j.ejon.2025.103014_bib8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/01.ede.0000246827.44093.c1","article-title":"Nurses with dermal exposure to antineoplastic drugs: reproductive outcomes","volume":"18","author":"Fransman","year":"2007","journal-title":"Epidemiology"},{"issue":"Suppl. 16b","key":"10.1016\/j.ejon.2025.103014_bib9","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.12968\/bjon.2017.26.Sup16b.S15","article-title":"A strategy for formulating regulation on CSTDs","volume":"26","author":"Field","year":"2017","journal-title":"Br. J. Nurs."},{"issue":"3","key":"10.1016\/j.ejon.2025.103014_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1188\/20.CJON.249-255","article-title":"Hazardous drug exposure case report analysis from a prospective, multisite study of oncology nurses' exposure in ambulatory settings","volume":"24","author":"Friese","year":"2020","journal-title":"Clin. J. Oncol. Nurs."},{"key":"10.1016\/j.ejon.2025.103014_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD012860.pub2","article-title":"Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff","author":"Gurusamy","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1\u20132","key":"10.1016\/j.ejon.2025.103014_bib12","first-page":"11","article-title":"Safe handling of cytotoxic drugs and risks of occupational exposure to nursing staffs","volume":"3","author":"Hanafi","year":"2015","journal-title":"J. Pharm. Care"},{"issue":"34","key":"10.1016\/j.ejon.2025.103014_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000034781","article-title":"The meta-analysis of sister chromatid exchange as a biomarker in healthcare workers with occupational exposure to antineoplastic drugs","volume":"102","author":"Hu","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.ejon.2025.103014_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijnurstu.2024.104907","article-title":"Knowledge and safe handling practices affecting the occupational exposure of nurses and midwives to hazardous drugs: a mixed methods systematic review","volume":"160","author":"van Huizen","year":"2024","journal-title":"Int. J. Nurs. Stud."},{"key":"10.1016\/j.ejon.2025.103014_bib15","article-title":"The experiences of cancer nurses working in four European countries: a qualitative study","volume":"49, 101844","author":"Kelly","year":"2020","journal-title":"Eur. J. Oncol. Nurs."},{"issue":"2","key":"10.1016\/j.ejon.2025.103014_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1188\/16.CJON.158-164","article-title":"Stress levels of nurses in oncology outpatient units","volume":"20","author":"Ko","year":"2016","journal-title":"Clin. J. Oncol. Nurs."},{"issue":"2","key":"10.1016\/j.ejon.2025.103014_bib17","article-title":"Environmental contamination with cytotoxic drugs in 15 hospitals from 11 European countries - results of the MASHA project","volume":"3","author":"Korczowska","year":"2020","journal-title":"Eur. J. Oncol. Pharm."},{"issue":"1","key":"10.1016\/j.ejon.2025.103014_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.NAJ.0000552583.69729.51","article-title":"Antineoplastic drug administration by pregnant and nonpregnant nurses: an exploration of the use of protective gloves and gowns","volume":"119","author":"Lawson","year":"2019","journal-title":"Am. J. Nurs."},{"issue":"10","key":"10.1016\/j.ejon.2025.103014_bib32","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.12968\/bjon.2020.29.10.S15","article-title":"Use of a closed-system drug transfer device reduces contamination with doxorubicin during bolus injection","volume":"29","author":"Marler-Hausen","year":"2020","journal-title":"Br. J. Nurs."},{"key":"10.1016\/j.ejon.2025.103014_bib19","series-title":"Einf\u00fchrung in Die Qualitative Sozialforschung","first-page":"59","article-title":"Verfahren qualitativ orientierter analyse","author":"Mayring","year":"2023"},{"issue":"1","key":"10.1016\/j.ejon.2025.103014_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4486\/j.op.2024.01.08","article-title":"Sichere Applikation von CMR-Medikamenten in der Onkologie 2.0","volume":"14","author":"Naegele","year":"2024","journal-title":"Onko Pflege"},{"issue":"3","key":"10.1016\/j.ejon.2025.103014_bib23","doi-asserted-by":"crossref","DOI":"10.3912\/OJIN.Vol9No03Man05","article-title":"Safe handling of hazardous drugs","volume":"9","author":"Polovich","year":"2004","journal-title":"Online J. Issues Nurs."},{"key":"10.1016\/j.ejon.2025.103014_bib24","series-title":"Safe Handling of Hazardous Drugs","author":"Polovich","year":"2018"},{"issue":"15","key":"10.1016\/j.ejon.2025.103014_bib25","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.2146\/ajhp180564","article-title":"ASHP guidelines on handling hazardous drugs","volume":"24","author":"Power","year":"2018","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.ejon.2025.103014_bib26","first-page":"491","article-title":"Risks to health professionals from hazardous drugs in Iran: a pilot study of understanding of healthcare team to occupational exposure to cytotoxics","volume":"13","author":"Shahrasbi","year":"2014","journal-title":"EXCLI J"},{"key":"10.1016\/j.ejon.2025.103014_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2024.102595","article-title":"Aspects of occupational safety, a survey among European cancer nurses","volume":"70","author":"Sharp","year":"2024","journal-title":"Eur. J. Oncol. Nurs."},{"issue":"16","key":"10.1016\/j.ejon.2025.103014_bib28","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.12968\/bjon.2017.26.16.S38","article-title":"Perceived adverse effects from handling systemic anti-cancer therapy agents","volume":"26","author":"Simons","year":"2017","journal-title":"Br. J. Nurs."},{"issue":"3","key":"10.1016\/j.ejon.2025.103014_bib29","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.ejon.2025.103014_bib30","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1470-2045(19)30163-9","article-title":"Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study","volume":"20","author":"Wilson","year":"2019","journal-title":"Lancet Oncol."}],"container-title":["European Journal of Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388925002388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388925002388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:31:27Z","timestamp":1764030687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1462388925002388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":29,"alternative-id":["S1462388925002388"],"URL":"https:\/\/doi.org\/10.1016\/j.ejon.2025.103014","relation":{},"ISSN":["1462-3889"],"issn-type":[{"value":"1462-3889","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"German cancer nurses and occupational exposure to cytotoxic drugs: A cross-sectional study with a mixed-methods approach","name":"articletitle","label":"Article Title"},{"value":"European Journal of Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejon.2025.103014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103014"}}